Grow strong within the company. Pen ~ fun ~ pavilion www.biquge.info

When he saw this message, Zhang Liuhaha laughed.

At a certain meeting, Johnson & Johnson's management also disagreed with the hype of Lorraine Pharmaceutical.

"Lorraine Pharmaceuticals has gone too far with hype this time."

"The results of the clinical trial have not yet come out, and the doctor who presided over the experiment is convinced that the experiment is 100% successful, which is too unrigorous."

"Hehe, I saw that when the bubble burst, how did their company step down."

"You are too careful, wait for three or four months, and when no ordinary people pay attention to this news, they will naturally be able to step down."

The atmosphere was very relaxed, and as the host Director Ma, he was also in a good mood.

"Lorraine is now in the past, so let's prepare for the upcoming launch of several drugs."

However, just two days before the Chinese New Year.

A piece of news from the drug review committee made Lorraine Pharmaceutical once again attract attention.

"The double-blind clinical trial of Lorraine Pharmaceutical has ended, and from the experimental results, this drug can indeed treat 100% of hepatitis B."

"Within three months, this new drug is expected to be on the market."

When this news came out, some ordinary people who paid attention to the incident seemed a little numb.

They don't know the weight of this committee, and the general public who question Lorraine still maintains a skeptical attitude, while some people who believe in Qian Yi and Lorraine still maintain a trusting attitude.

But this news has made the pharmaceutical industry boil.

Inside a pharmaceutical company.

"How is it possible for Lorraine to develop a drug to treat hepatitis B? How did they do it!? ”

in another pharmaceutical company.

"Our company has a generic drug for the treatment of hepatitis B on the market, everyone should pay close attention to the relevant information!"

It is also in Qiantang, a company that has dealt with Lorraine Pharmaceutical.

"No matter what the price, you will dig up the money for me! If you can't dig 50 million, you can use 100 million! ”

Grow strong within the company.

The management of Shengqiang Company in Greater China, which has received the latest news, is considering countermeasures.

"Ladies and gentlemen, according to the inside information I received, Lorraine Pharmaceutical's hepatitis B treatment drug has indeed been successfully developed. Dozens of cases participating in the experiment have all turned from clinically positive to negative. ”

In the huge conference room, there was an audible silence in an instant.

"Impossible! The inflammation caused by the hepatitis B virus is not so easy to treat! If there are no antibodies, it is impossible for liver cells to clean up the virus on their own! A drug development executive in China still doesn't believe the news.

"Many people have said before that rabies is incurable, but Lorraine Pharmaceutical has developed a drug to treat it." A faint voice rang out on the side.

The director in charge of drug development was instantly muted, and the conference room fell silent again.

"Let's analyze how much impact the successful research of hepatitis B treatment drugs has on our company." As the head of Greater China, Director Ma, who was sitting in the lead, asked in a calm voice.

"Director Ma, hepatitis B drugs are an important source of profit for our company, accounting for about 2% of the company's total revenue." A supervisor lifted his glasses and said, "If Lorraine Pharmaceuticals really develops a drug to treat hepatitis B, then our company will completely lose revenue from this business." ”

“2%？ That doesn't seem to be a high number. ”

At the most untouched position, Zhang Liu's voice sounded as if he was comforting himself.

"Director Zhang, the proportion of two percent is indeed not high...... But Director Zhang should not forget that there are other diseases caused by the hepatitis B virus, such as liver cirrhosis, fatty liver, and liver cancer. The supervisor continued: "At least six percent of our company's revenue is related to this. ”

Hepatitis B is not a terminal disease, but the probability of suffering from other liver diseases is several times or even more than ten times that of ordinary people.

It is conceivable that if the drugs developed by Lorraine Pharmaceutical are popularized, in ten years, the number of liver disease patients in Huaxia will be reduced by one-third or even more.

At that time, their company's related business will definitely be affected.

Once again, the supervisors fell silent.

The drug researched by Lorraine Pharmaceutical has indeed affected many people's jobs!

In China, tens of billions or even hundreds of billions of medical expenses are invested in the prevention and treatment of liver diseases every year. Now, as long as the kind of drug that Lorraine Pharmaceutical has on hand is promoted, the market will shrink considerably!

Zhang Liu's face had already begun to turn pale.

"The head office is researching a new generation of targeted drugs for the treatment of liver cancer, and has invested nearly $200 million in the project." The head of development reminded: "Guys, if hepatitis B is really prevented, the audience for this drug will be greatly reduced. ”

At that time, the benefits of this project will also be greatly reduced!

"My concern is that if this drug passes the FDA review and enters the North American market, it will have an impact on the headquarters." A middle-aged man with slightly white hair who was sitting near Director Ma glanced at the scene and said.

When Director Ma heard this, he showed a hint of heaviness.

"There are nearly 13 million people living with hepatitis B in North America." The gray-haired middle-aged man reminded: "Even if only 50 percent of these patients buy this new drug, it is an incomparably vast market." We want to get the right to represent and even license this drug in North America. ”

"Director Wang, because of the agency problem of Lorraine Ferment, we had some unpleasantness with Lorraine Pharmaceutical before." Director Ma hesitated and said.

"What is this little thing in the face of huge interests?" Director Wang sighed.

The others also nodded their heads when they heard this.

What is the trifle of the risk of declining performance for the new drug produced by Lorraine Pharmaceuticals, which would cost the company more than $1 billion a year in sales if it were rolled out?

"Director Zhang, I have always communicated with you Lorraine Pharmaceutical before, and now, you are also responsible for this matter." Director Ma said to Zhang Liudao, who was sitting in the last seat.

"I, I ...... this thing," Zhang Liu said with a little snort.

"Director Ma, I think it's better for you to come forward in this matter." Director Wang said suddenly.

As long as the head of the Greater China region comes forward, they can show their sincerity.

"Don't forget, we're facing other competitors."

Although Shengqiang is a world-class pharmaceutical giant, it still has one or two competitors of the same level in the North American market.

"I see." Director Xiao stood up and said, "I'll go and contact Mr. Xiao now." (To be continued.) )